Search by Drug Name or NDC

    NDC 63287-0419-01 RELEEV Cold Sore Treatment 1.3 mg/mL Details

    RELEEV Cold Sore Treatment 1.3 mg/mL

    RELEEV Cold Sore Treatment is a TOPICAL LIQUID in the HUMAN OTC DRUG category. It is labeled and distributed by Merix Pharmaceutical Corp.. The primary component is BENZALKONIUM CHLORIDE.

    Product Information

    NDC 63287-0419
    Product ID 63287-419_e3da5cc2-c71d-3a22-e053-2995a90adfeb
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name RELEEV Cold Sore Treatment
    Proprietary Name Suffix n/a
    Non-Proprietary Name Benzalkonium Chloride
    Product Type HUMAN OTC DRUG
    Dosage Form LIQUID
    Route TOPICAL
    Active Ingredient Strength 1.3
    Active Ingredient Units mg/mL
    Substance Name BENZALKONIUM CHLORIDE
    Labeler Name Merix Pharmaceutical Corp.
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part333A
    Listing Certified Through 2024-12-31

    Package

    NDC 63287-0419-01 (63287041901)

    NDC Package Code 63287-419-01
    Billing NDC 63287041901
    Package 1 POUCH in 1 BLISTER PACK (63287-419-01) / 1 BOTTLE, DROPPER in 1 POUCH / 1 mL in 1 BOTTLE, DROPPER
    Marketing Start Date 2006-06-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL fcef2fd3-2f32-4fb0-b396-ba4481ca4ccf Details

    Revised: 7/2022